The Food and Drug Administration just granted permission for “expanded access” to an experimental medicine for Ebola. It’s OK as far as it goes, but it’s an exception to the FDA’s reluctance to approve the use of life-saving products.
As we start the final stretch before the midterm elections, many analysts are convinced that Obamacare isn't the hot political issue it once was. While the flood of negative publicity about the law has subsided of late, a majority of people still oppose it, according to a Real Clear Politics average of polls taken from Sept. 2-15.
On August 28 the New York Times published a provocative article entitled “Medicare: Not Such a Budget Buster Anymore.” Its thesis was that Medicare no longer poses the budgetary threat it was projected to just a few years ago (the New York Times piece contrasts current projections with those made in 2006), thanks in part to the Affordable Care Act and other changes in the healthcare sector.
The Working Group on Health Care Policy devises public policies that enable more Americans to get better value for their health care dollar and foster appropriate innovations that will extend and improve life.